SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-050490
Filing Date
2021-08-09
Accepted
2021-08-09 19:56:42
Documents
1
Period of Report
2021-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4036
  Complete submission text file 0001209191-21-050490.txt   5412
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Issuer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address
Royan Ajay (Reporting) CIK: 0001875614 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40703 | Film No.: 211158001